February 7, 2024
9:00am – 10:00am
Venue
Zoom
“Development of a Disease-Modifying Drug for GBA-Parkinson’s Disease”
Peter Lansbury, Ph.D.
Chief Scientific Officer, Lysosomal Therapeutics, Inc.
Professor of Neurology, Harvard Medical School
Virtual Event
Zoom Webinar (Passcode: 123456)
For more information, please contact Paulina Castellanos at PCastellanos@mednet.ucla.edu.